Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Tap

Showing results (121-130 of 235) with videos related to

Pageof 24
Sort By:
NPJ Precision Oncology|March 25, 2025
Immunologic correlates in a CIC::DUX4 fusion-positive sarcoma responsive to dual immune checkpoint blockadeOlayode O Babatunde, Sara Coca Membribes, Cristina Anthonescu, et al.
Journal of Patient-Reported Outcomes|February 5, 2019
The measurement of physical functioning among patients with Tenosynovial Giant Cell Tumor (TGCT) using the Patient-Reported Outcomes Measurement Information System (PROMIS)Heather L Gelhorn, Xin Ye, Rebecca M Speck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2012
Phase I/IIa trial of the mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) administered orally in patients with refractory or advanced malignancies and sarcomaM M Mita, E Poplin, C D Britten, et al.
JAMA Oncology|April 29, 2016
Progression-Free Survival Among Patients With Well-Differentiated or Dedifferentiated Liposarcoma Treated With CDK4 Inhibitor Palbociclib: A Phase 2 Clinical TrialMark A Dickson, Gary K Schwartz, Mary Louise Keohan, et al.
Sarcoma|June 18, 2016
Overall Survival and Response to Systemic Therapy in Metastatic Extrauterine LeiomyosarcomaA N Shoushtari, J Landa, D Kuk, et al.
International Journal of Radiation Oncology, Biology, Physics|December 30, 2014
Inhibition of vascular endothelial growth factor A and hypoxia-inducible factor 1α maximizes the effects of radiation in sarcoma mouse models through destruction of tumor vasculatureHae-June Lee, Changhwan Yoon, Do Joong Park, et al.
Sarcoma|October 1, 2019
Safety and Efficacy of Hepatic Artery Embolization in Treating Solitary Fibrous Tumor Metastatic to the LiverSara Velayati, Joseph P Erinjeri, Lynn A Brody, et al.
Cancer Chemotherapy and Pharmacology|February 13, 2015
Alliance A091103 a phase II study of the angiopoietin 1 and 2 peptibody trebananib for the treatment of angiosarcomaSandra P D' Angelo, Michelle R Mahoney, Brian A Van Tine, et al.
Cancers|July 14, 2023
Assessing the Needs of Those Who Serve the Underserved: A Qualitative Study among US Oncology CliniciansManali I Patel, Leslie Hinyard, Fay J Hlubocky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2019
Genomic Profiling Identifies Association of <i>IDH1/IDH2</i> Mutation with Longer Relapse-Free and Metastasis-Free Survival in High-Grade ChondrosarcomaGuo Gord Zhu, Khedoudja Nafa, Narasimhan Agaram, et al.
Pageof 24

Showing results (121-130 of 235) with videos related to

Sort By:
Pageof 24
NPJ Precision Oncology|March 25, 2025
Immunologic correlates in a CIC::DUX4 fusion-positive sarcoma responsive to dual immune checkpoint blockadeOlayode O Babatunde, Sara Coca Membribes, Cristina Anthonescu, et al.
Journal of Patient-Reported Outcomes|February 5, 2019
The measurement of physical functioning among patients with Tenosynovial Giant Cell Tumor (TGCT) using the Patient-Reported Outcomes Measurement Information System (PROMIS)Heather L Gelhorn, Xin Ye, Rebecca M Speck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2012
Phase I/IIa trial of the mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) administered orally in patients with refractory or advanced malignancies and sarcomaM M Mita, E Poplin, C D Britten, et al.
JAMA Oncology|April 29, 2016
Progression-Free Survival Among Patients With Well-Differentiated or Dedifferentiated Liposarcoma Treated With CDK4 Inhibitor Palbociclib: A Phase 2 Clinical TrialMark A Dickson, Gary K Schwartz, Mary Louise Keohan, et al.
Sarcoma|June 18, 2016
Overall Survival and Response to Systemic Therapy in Metastatic Extrauterine LeiomyosarcomaA N Shoushtari, J Landa, D Kuk, et al.
International Journal of Radiation Oncology, Biology, Physics|December 30, 2014
Inhibition of vascular endothelial growth factor A and hypoxia-inducible factor 1α maximizes the effects of radiation in sarcoma mouse models through destruction of tumor vasculatureHae-June Lee, Changhwan Yoon, Do Joong Park, et al.
Sarcoma|October 1, 2019
Safety and Efficacy of Hepatic Artery Embolization in Treating Solitary Fibrous Tumor Metastatic to the LiverSara Velayati, Joseph P Erinjeri, Lynn A Brody, et al.
Cancer Chemotherapy and Pharmacology|February 13, 2015
Alliance A091103 a phase II study of the angiopoietin 1 and 2 peptibody trebananib for the treatment of angiosarcomaSandra P D' Angelo, Michelle R Mahoney, Brian A Van Tine, et al.
Cancers|July 14, 2023
Assessing the Needs of Those Who Serve the Underserved: A Qualitative Study among US Oncology CliniciansManali I Patel, Leslie Hinyard, Fay J Hlubocky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2019
Genomic Profiling Identifies Association of <i>IDH1/IDH2</i> Mutation with Longer Relapse-Free and Metastasis-Free Survival in High-Grade ChondrosarcomaGuo Gord Zhu, Khedoudja Nafa, Narasimhan Agaram, et al.
Pageof 24